These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21324826)

  • 1. Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism.
    Ishay A; Herer P; Luboshitzky R
    Endocr Pract; 2011; 17(4):584-90. PubMed ID: 21324826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
    BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance before and after parathyroidectomy in patients with primary hyperparathyroidism--a pilot study.
    Rudman A; Pearson ER; Smith D; Srivastava R; Murphy MJ; Leese GP
    Endocr Res; 2010 May; 35(2):85-93. PubMed ID: 20408756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism.
    Karakose M; Caliskan M; Arslan MS; Demirci T; Karakose S; Cakal E
    Endocrine; 2017 Jan; 55(1):283-288. PubMed ID: 27844209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
    Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.
    Piovesan A; Molineri N; Casasso F; Emmolo I; Ugliengo G; Cesario F; Borretta G
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):321-8. PubMed ID: 10435057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism.
    Bhadada SK; Bhansali A; Shah VN; Rao DS
    Singapore Med J; 2011 Dec; 52(12):890-3. PubMed ID: 22159932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment.
    Valdemarsson S; Lindblom P; Bergenfelz A
    J Intern Med; 1998 Sep; 244(3):241-9. PubMed ID: 9747747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
    Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors in primary hyperparathyroidism.
    Luboshitzky R; Chertok-Schaham Y; Lavi I; Ishay A
    J Endocrinol Invest; 2009 Apr; 32(4):317-21. PubMed ID: 19636198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising Glucagon-Like Peptide 1 Concentrations After Parathyroidectomy in Patients With Primary Hyperparathyroidism.
    Antonopoulou V; Karras SN; Koufakis T; Yavropoulou M; Katsiki N; Gerou S; Papavramidis T; Kotsa K
    J Surg Res; 2020 Jan; 245():22-30. PubMed ID: 31400574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.
    Osto E; Fallo F; Pelizzo MR; Maddalozzo A; Sorgato N; Corbetti F; Montisci R; Famoso G; Bellu R; Lüscher TF; Iliceto S; Tona F
    Circulation; 2012 Aug; 126(9):1031-9. PubMed ID: 22821942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
    Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
    Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.
    de la Plaza Llamas R; Ramia Ángel JM; Arteaga Peralta V; García Amador C; López Marcano AJ; Medina Velasco AA; González Sierra B; Manuel Vázquez A; Latorre Fragua RA
    Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):659-669. PubMed ID: 29209851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.
    Trinh G; Rettig E; Noureldine SI; Russell JO; Agrawal N; Mathur A; Prescott JD; Zeiger MA; Tufano RP
    Otolaryngol Head Neck Surg; 2018 Oct; 159(4):630-637. PubMed ID: 30105919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study.
    Norenstedt S; Pernow Y; Brismar K; Sääf M; Ekip A; Granath F; Zedenius J; Nilsson IL
    Eur J Endocrinol; 2013 Dec; 169(6):795-804. PubMed ID: 24026893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
    Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
    BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review.
    Pepe J; Cipriani C; Sonato C; Raimo O; Biamonte F; Minisola S
    Eur J Endocrinol; 2017 Dec; 177(6):R297-R308. PubMed ID: 28864535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.
    Hagström E; Lundgren E; Rastad J; Hellman P
    Eur J Endocrinol; 2006 Jul; 155(1):33-9. PubMed ID: 16793947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.